and C.W., 82203156 to S.Z., 824B2085 to Liang Zhu), the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2025-I2M-KJ-003, 2025-I2M-XHZY-016, 2025-I2M-GCC-002 and 2023-I2M-2-004 to C.W.), the National Key Research and Development Program of China (2023YFC3503200 to S.Z), the National High Level Hospital Clinical Research Funding (2025-LYZX-D-B04 to D.L., 2025-LYZX-C-B01 to C.W)
The peptide functions as a precision senolytic agent by competing with endogenous FOXO4 for p53 binding, releasing the tumor suppressor protein to trigger apoptosis specifically in cells that have accumulated the senescence-associated secretory phenotype (SASP) markers
Parkinson's disease and other extrapyramidal disorders
We perform tests on our products regularly with the relevant types of equipment
The dosing ranges referenced are derived from preclinical research models and observational, non-clinical protocols